Information for Patients

Your Care at the Ottawa Blood Disease Centre

If you need to be seen by one of our specialists, your physician will need to fax us a referral.

Once the referral is received, it is entered into our database and reviewed by a physician to determine the type of consult needed. Within 2 working days, we will contact your physician to let them know that we have received your referral, and we will advise them if there are any issues (e.g. wrong type of referral, missing information, etc.)

Next, your consult is distributed to a physician’s office to book an appointment in one of our clinics:

Within 2 weeks, we will contact your physician with an appointment date OR an estimate, within a 2 month timeframe, of when the appointment will occur.

All referrals are triaged so that people with the most urgent problems are seen most quickly. The OBDC has established wait time guidelines based on clinical need; your appointment will be scheduled according to these guidelines. If you are unsure of whether you have been scheduled for an appointment, please contact your physician’s office. You may be required to complete some bloodwork prior to your visit.

Our clinics, inpatient and outpatient programs are centralized at the General Campus. Thrombosis care is also available at satellite clinics across the LHIN and via telemedicine. Satellite and/or telemedicine clinics are located at the following hospitals:

  • HĂ´pital Montfort
  • Pembroke Regional Hospital
  • Cornwall Community Hospital
  • Hawkesbury & District General Hospital
  • Renfrew Victoria Hospital


Research at the Ottawa Blood Disease Centre

Our team is devoted to conducting life-saving research for patients with blood diseases. You may have the opportunity to participate. Do you have questions about what it means to be involved in research? Explore some of the most Frequently Asked Questions or read more about our research program.

We are a very active research group with many studies underway. If your doctor feels you might be a good candidate for one of our current studies, he or she may discuss it with you so you could decide if you wanted to participate. You are under no obligation to participate in any study, and your consent to participate would be documented in writing.

You might ask why you would want to participate in research.

  • You would receive care from a research team that includes doctors and health care professionals who are familiar with the most advanced treatments possible;
  • You would have a second set of ‘guardian angels’ to help you through the process of care;
  • Research participants are not “guinea pigs”…researchers have strict rules that must be followed in order to keep patients safe;
  • The results from your participation may help researchers develop new treatments that can improve the quality of life for future patients with the same disorder;
  • You would have the opportunity to learn more about an illness/disease and how to take care of it; and
  • You would have the satisfaction of contributing to medical knowledge, including helping to identify possible new treatments.


Blood Diseases

Here are some definitions of blood diseases we frequently treat.

Anemia: A deficiency in the oxygen-carrying component of the blood, as in the amount of hemoglobin or the number or volume of red blood cells. Iron deficiency, often caused by inadequate dietary consumption of iron, and blood loss are common causes of anemia.

Hemophilia: Any of several hereditary blood-coagulation disorders in which the blood fails to clot normally because of a deficiency or abnormality of one of the clotting factors. Hemophilia, a recessive trait associated with the X-chromosome, is manifested almost exclusively in males.

Leukemia: Any of various acute or chronic neoplastic diseases of the bone marrow in which unrestrained proliferation of white blood cells occurs, usually accompanied by anemia, impaired blood clotting, and enlargement of the lymph nodes, liver, and spleen.

Lymphoma: Any of various usually malignant tumors that arise in the lymph nodes or in other lymphoid tissue.

Myeloma: A malignant tumour formed by the cells of the bone marrow.

Thalassemia: An inherited form of anemia occurring chiefly among people of Mediterranean descent, caused by faulty synthesis of part of the hemoglobin molecule.

Thrombosis: Coagulation of the blood within a blood vessel in any part of the circulatory system. Click here to watch a video about the signs and symptoms of a blood clot.




How You Can Help

There are many ways you can help the Ottawa Blood Disease Centre continue to provide excellent patient care and conduct life-saving research.